N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 5, 2003, Pages 1513-1520

  Tossios, Paschalis ^a   Bloch, Wilhelm ^a   Huebner, Astrid ^a   Raji, M Reza ^a   Dodos, Fotini ^a   Klass, Oliver ^a   Suedkamp, Michael ^a   Kasper, Stefan Mario ^a   Hellmich, Martin ^a   Mehlhorn, Uwe ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLCYSTEINE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITOMETRY; DOUBLE BLIND PROCEDURE; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART STRESS; HEART SURGERY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 10744227003     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00968-1     Document Type: Article

References (28)

1. Droege W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
2. Sekili S, McCay PB, Li X-Y, Zughaib M, Sun J-Z, Tang L, et al. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial "stunning" in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. Circ Res. 1993;73:705-23.
3. Li X-Y, McCay PB, Zughaib M, Jeroudi MO, Triana F, Bolli R. Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of the major differences between conscious and open-chest dogs. J Clin Invest. 1993;92:1025-41.
4. Davies SW, Ranjadayalan K, Wickens DC, Dorinandy TL, Tinunis AD. Lipid peroxidation associated with successful thrombolysis. Lancet. 1990;335:741-3.
5. Grech ED, Dodd HF, Bellamy CM, PERRY RA, Morrison WL, Ramsdale DR. Free radical generation during angioplasty reperfusion for acute myocardial infarction. Lancet. 1993;341:990-1.
6. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, et al. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prosta-glandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation. 1997;96: 3314-20.
7. Coghlan JG, Flitter WD, Clutton SM, Panda R, Daly R, Wright G, et al. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary bypass grafting. J Thorac Cardiovasc Surg. 1994:107:248-56.
8. Mehlhorn U, Krahwinkel A, Geissler HJ, Larosee K, Fischer UM, Klass O, et al. Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg. 2003;125:178-83.
9. Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett. 2000;470:1-6.
10. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, Bauer JA. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res. 2001;49:798-807.
11. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res. 2001;89:279-86.
12. Sisto T, Paajanen H, Metsa-Ketela T, Harmoinen A, Nordback I, Tarkka M. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg. 1995;59:1519-23.
13. Clancy RR, McGaurn SA, Goin JE, Hirtz DG, Norwood WI, Gaynor JW, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics. 2001;108:61-70.
14. Menasche P, Pasquier C, Belluci S, Lorente P, Jaillon P, Piwnica A. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg. 1988;96:582-9.
15. Andersen LW, Thiis J, Kharazmi A, Rygg I. The role of N-acetylcysteine administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion. 1995;10:21-6.
16. Kelly GS. Clinical application of N-acetylcysteine. Altern Med Rev. 1998;3:114-27.
17. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zideck W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343: 210-2.
18. Moher D, Schulz KF, Altman DG. for the CONSORT group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001; 357:1191-4.
19. Clements FM, Harpole DH, Quill T, Jones RH, McCann RL. Estimation of left ventricular volume and ejection fraction by two-dimensional transesophageal echocardiography: comparison of short axis imaging and simultaneous radionuclide angiography. Br J Anesth. 1990;64:331-6.
20. Nonami Y. The role of nitric oxide in cardiac ischemia-reperfusion injury. Jpn Circ J. 1997;61:119-32.
21. Bloch W, Mehlhorn U, Kiahwinkel A, Reiner M, Dittrich M, Schmidt A, et al. Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide. 2001;5:317-33.
22. Depré C, Fierain L, Hue L. Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc Res. 1997;33:82-7.
23. Mehlhorn U, Bloch W, Krahwinkel A, LaRose K, Geissler HJ, Hekmat K, et al. Activation of myocardial constitutive nitric oxide synthase during coronary artery surgery. Eur J Cardiothorac Surg. 2000;17: 305-11.
24. Mobert J, Becker BF, Zahler S, Gerlach E. Hemodynamic effects of isoprostanes (8-iso-prostraglandin F2alpha and E2) in isolated guinea-pig hearts. J Cardiovasc Pharmacol. 1997;29:789-94.
25. Gupte SA, Okada T, Tateyama M, Ochi R. Activation of TxA2/PGH2 receptors and protein kinase C contribute to coronary dysfunction in superoxide treated rat hearts. J Mol Cell Cardiol. 2000:32:937-46.
26. Digerness SB, Harris KD, Kirklin JW, Urthaler F, Viera L, Beckman JS, et al. Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic Biol Med. 1999;27:1386-92.
27. Feng Q, Lu X, Jones DL, Shen J, Arnold JM. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation. 2001;104:700-4.
28. Gupte SA, Okada T. Prostaglandins and nitric oxide mediate superoxide-induced myocardial contractile dysfunction in isolated rat hearts. J Mol Cell Cardiol. 2001;33:1107-17.